Midgard Science

Labs / ADME, DMPK & toxicology

Avacta Therapeutics

London, United Kingdom · avacta.com

On your own

Free. Their own form.

Contact Avacta Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Avacta Therapeutics is a clinical stage biopharmaceutical company developing tumor-activated oncology delivery platforms. It develops pre|CISION® peptide drug conjugates to deliver existing cancer therapeutics more selectively to tumors, with operations in London, United Kingdom.

They take quote requests by email.

What they offer

  • pre|CISION® tumor-activated oncology delivery platform

    Develops a peptide drug conjugate platform that masks a toxic payload until it is selectively released by fibroblast activation protein (FAP) in the tumor microenvironment.

  • Faridoxorubicin (AVA6000) clinical development

    Develops a Gen One pre|CISION® peptide drug conjugate form of doxorubicin that has completed Phase 1a testing and is in Phase 1b expansion cohorts.

  • FAP-Exd (AVA6103) clinical development

    Develops a Gen Two pre|CISION® sustained-release version of exatecan that is in Phase 1 testing in multiple disease settings.

What they work on

Modalities
Antibody, ADC, Peptide
Therapeutic areas
oncology, cancer
Sites
London, United Kingdom
Address
58 Wood Lane London W12 7RZ

Similar labs. Aurigene Pharmaceutical Services, Glykos, Manhattan BioSolutions, Oncodesign Services

Found in a contract services directory. Listing built from avacta.com. Work here? Claim this listing.

Avacta Therapeutics · Midgard Science